Article

AJMC® in the Press, November 5, 2021

Author(s):

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A blog post by PhRMA referenced a study published in the October 2021 issue of The American Journal of Managed Care® (AJMC®). The study, “340B Drug Pricing Program and Hospital Provision of Uncompensated Care,” found that participation in the 340B Drug Pricing Program by general acute care hospitals and critical access hospitals has not been associated with increased provision of uncompensated care.

A piece by Oil City News cited an article published on AJMC.com, the website of AJMC®. The article, “A Timeline of COVID-19 Developments in 2020,” reviewed how the pandemic evolved and progressed through 2020, which closed with the arrival of vaccines but also continued challenges.

Related Videos
Corey McEwen, PharmD, MS
Kirollos Hanna, PharmD
Jessica Meyers, MSEd, and Amy Herschell PhD
Benjamin Scirica, MD, MPH, associate professor of medicine at Harvard Medical School and director of quality initiatives at Brigham and Women’s Hospital’s Cardiovascular Division
Laurence Sperling, MD
Screenshot of an interview with A. Mark Fendrick, MD
dr jennifer green
dr ken cohen
dr ian neeland
dr manisha jhamb
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo